Xiao-Hong Yang Selected Research

Xiao-Hong Yang Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 05/2008
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2019 - 11/2011
3	Inflammation (Inflammations) 04/2023 - 02/2002
3	Atrial Fibrillation 01/2023 - 01/2022
3	Hemorrhage 01/2022 - 01/2015
3	Hypoxia (Hypoxemia) 01/2022 - 07/2012
3	Leukemia 06/2010 - 12/2002
2	Stroke (Strokes) 01/2023 - 11/2018
2	Acute Coronary Syndrome 01/2022 - 11/2018
2	Fibrosis (Cirrhosis) 01/2022 - 08/2013
2	Thyroid Diseases (Thyroid Disease) 01/2022 - 01/2015
2	Neoplasm Metastasis (Metastasis) 12/2020 - 10/2012
2	Myocardial Infarction 11/2020 - 01/2012
2	Turner Syndrome (Turner's Syndrome) 01/2019 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 03/2017 - 07/2016
2	Skin Neoplasms (Skin Cancer) 11/2016 - 10/2016
2	Hepatocellular Carcinoma (Hepatoma) 10/2012 - 07/2010
2	Pathologic Neovascularization 09/2012 - 07/2006
2	Ischemia 01/2012 - 01/2002
1	CHARGE Syndrome 02/2024
1	Allergic Rhinitis 04/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Hyperthyroidism 01/2022
1	Hypothyroidism 01/2022
1	Ureteral Obstruction 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Heart Failure 11/2020
1	Hypotension (Low Blood Pressure) 07/2020
1	Systolic Heart Failure 07/2020
1	Sudden Death 07/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Bites and Stings (Sting) 01/2020
1	Pediatric Obesity 12/2019
1	Cytopenia 05/2019
1	Carcinoma (Carcinomatosis) 04/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2019
1	Dyspnea (Shortness of Breath) 11/2018
1	Lung Neoplasms (Lung Cancer) 04/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2016
5	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2002
4	PowdersIBA 05/2019 - 11/2011
4	qinghuangIBA 05/2019 - 11/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 07/2006
3	CytokinesIBA 04/2023 - 06/2014
2	Clopidogrel (Plavix)FDA Link 01/2022 - 11/2018
2	yishenIBA 05/2019 - 11/2011
2	Taurine FDA Link 04/2019 - 04/2018
2	Phosphotransferases (Kinase)IBA 04/2019 - 01/2016
2	Therapeutic UsesIBA 01/2018 - 06/2014
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2008 - 04/2007
2	AntigensIBA 02/2006 - 02/2002
1	NucleosidesIBA 02/2024
1	Antiviral Agents (Antivirals)IBA 02/2024
1	NucleotidesIBA 02/2024
1	Messenger RNA (mRNA)IBA 04/2023
1	Budesonide (Pulmicort)FDA LinkGeneric 04/2023
1	Albuterol (Salbutamol)FDA LinkGeneric 04/2023
1	OvalbuminIBA 04/2023
1	Theophylline (Theon)FDA LinkGeneric 04/2023
1	montelukast (Singulair)FDA Link 04/2023
1	Long Noncoding RNAIBA 01/2023
1	Competitive Endogenous RNAIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	iodoazomycin arabinosideIBA 01/2022
1	RivaroxabanIBA 01/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2022
1	AnticoagulantsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	EnzymesIBA 01/2022
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2022
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	LipidsIBA 12/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2020
1	Atorvastatin (Lipitor)FDA Link 11/2020
1	pro-brain natriuretic peptide (1-76)IBA 07/2020
1	Simendan (Levosimendan)IBA 07/2020
1	InterferonsIBA 01/2020
1	acridoneIBA 01/2020
1	vadimezanIBA 01/2020
1	Angiopoietin-Like Protein 4IBA 12/2019
1	Glucagon (Glukagon)FDA Link 12/2019
1	Radiation-Sensitizing AgentsIBA 03/2019
1	AdipokinesIBA 01/2019
1	AdiponectinIBA 01/2019
1	TicagrelorIBA 11/2018
1	Diphosphates (Pyrophosphates)IBA 11/2018
1	Gemcitabine FDA Link 01/2018
1	fluoroazomycin arabinosideIBA 01/2018
1	RadiopharmaceuticalsIBA 01/2018
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2018
1	hydroxide ionIBA 11/2017

Therapy/Procedure

6	Therapeutics 01/2022 - 07/2012
4	Aftercare (After-Treatment) 09/2017 - 06/2010
2	Drug Therapy (Chemotherapy) 01/2018 - 05/2008
1	Catheter Ablation 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Immunotherapy 01/2020